Are you Dr. Kessel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-890-9600Fax+1 608-890-7181
Summary
- Dr. Julie Kessel, MD is a neonatologist in Madison, Wisconsin. She is currently licensed to practice medicine in Wisconsin, Georgia, and Utah. She is affiliated with UnityPoint Health Meriter and University Hospital.
Education & Training
- University of Utah HealthFellowship, Neonatal-Perinatal Medicine, 1994 - 1997
- Emory University School of MedicineResidency, Pediatrics, 1991 - 1994
- University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
- WI State Medical License 1998 - 2025
- UT State Medical License 1994 - 2000
- GA State Medical License 1994 - 1995
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 66 citationsLaryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial.Kari D Roberts, Roland Brown, Andrea L. Lampland, Tina A. Leone, Kyle Rudser
The Journal of Pediatrics. 2017-11-22 - 25 citationsCoengagement of ICAM-3 and Fc Receptors Induces Chemokine Secretion and Spreading by Myeloid LeukocytesJulie M. Kessel, Joel S. Hayflick, Andrew S. Weyrich, Patricia A. Hoffman, Michael Gallatin
Journal of Immunology. 1998-06-01 - 4 citationsLigation of intercellular adhesion molecule 3 induces apoptosis of human blood eosinophils and neutrophilsJulie M. Kessel, Julie B. Sedgwick, William W. Busse
The Journal of Allergy and Clinical Immunology. 2006-10-01
Press Mentions
- As Sequencing Moves into Clinical Use, Insurers BalkJune 19th, 2014